Navigation Links
Resistant tumors could be treated with the discovery of a new molecule within cancer cells

A new research study published in the journal, Cancer Cell reported that scientists have discovered why some tumors respond less well to drug treatment as compared to others. Researchers have found that high levels of a specific molecule within cancer cells seem to block the effect of drugs such as Taxol, which are used to treat a number of cancers in their later stages. In the study, the// researchers focused on a molecule called AURORA-A which is found at higher than normal levels in up to half of breast and bowel tumors, and in many other kinds of cancer. They genetically engineered cervical cancer cells with the gene for AURORA-A in order to increase levels of the molecule. They found that when treated with Taxol only about half as many engineered cells were killed by the drug as non-engineered cells.

In normal cell division, a cell can only divide if it has correctly shared out all its genes, ensuring each new cell receives a complete set. If there is a problem with the process of sharing out genes, an alarm will be triggered and the cell will not divide. However, cells with high amounts of AURORA-A seemed to over-ride the alarm and continue to divide, even when their genes were not correctly shared out. This ability to ignore the alarm could make them resistant to Taxol-type drugs. Lead researcher, Ashok Venkitaraman said that high amounts of AURORA-A seemed to make cancer cells less sensitive to treatment and a new test to look for the molecules in the tumor to predict how effective Taxol treatment is likely to be. The findings that are yet to be confirmed in cancer patients, raises the additional possibility that new drugs which inactivate the molecule could boost the response of cancer cells to treatment.


Page: 1

Related medicine news :

1. Hope for Chemo-Resistant Leukemia Patients
2. Understanding Gene Profiles Could Help Cure A Resistant Form Of Leukemia In Kids
3. HIV Virus Emerging Drug Resistant In UK, Prompting Fear Of A Second Epidemic
4. 90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose
5. Resistant Influenza strains creates panic in US
6. Treatment Resistant Tumors Can Be Targeted Better Using Botox
7. New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment
8. ‘Drug Resistant TB’ Rattles the Union Ministy
9. Malaria Resistant Mosquitoes Could Help In Combating Malaria
10. Tumor Resistant Mice Point To Novel Cancer Treatments
11. Mad-Cow Resistant Calf Cloned in China
Post Your Comments:

(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
(Date:10/12/2017)... ... 12, 2017 , ... Women-owned and Grand Rapids-based workplace wellness ... in Wellness® by Best and Brightest. OnSite Wellness will be honored at the ... 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located at ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... University of California Berkeley, and other leading institutions in announcing the launch of ... institutions to change the way animals are raised for food. , Founding members ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... -- Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an ... Puerto Rico , where the company ... Following a comprehensive onsite assessment, ... damage, temporary loss of power and minimal water damage ... operations have resumed, and the company expects to return ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
(Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
Breaking Medicine Technology: